Ablation is a relatively new paradigm in interventional and surgical technologies, but has rapidly become accepted by many clinical specialties, with growing caseload
Foothill Ranch, CA (PRWEB) September 12, 2008
Treating tissue surgically or interventionally with more demanding clincial end-points requires methods that cannot be achieved wtih traditional instrumentation. The ability to cut, coagulate, excise, and produce other tissue effects with better outcomes, including fewer complications for a wide range of clinical applications demands a diverse portfolio of innovative, energy-based technologies encompassing electrosurgery, radiosurgery, gamma knife, brachytherapy, cryogenic therapy, fluidjet therapy (hydrotherapy), microwave ablation, radiofrequency ablation, laser, thermal ablation, and ultrasonic ablation. Some of these technologies have more extensive clinical histories than others, but all are being aggressively pursued for their ability to competitively produce desired clinical results.
"Ablation is a relatively new paradigm in interventional and surgical technologies, but has rapidly become accepted by many clinical specialties, with growing caseload," says Patrick Driscoll, President of MedMarket Diligence, publisher of the "Worldwide Ablation Technologies" report. According to Driscoll, the bulk of ablation technologies are being used in the treatment of cardiovascular disease, notably arrhythmia, but applications in cancer, general and elective surgery, orthopedic surgery and others are rapidly expanding also. "This is driving the $25 billion market at double digit rates," says Driscoll.
The MedMarket Diligence report, "Worldwide Ablation Technologies, 2008-2017," is a detailed market and technology assessment and forecast of the products and technologies in the ablation market for treatment of soft tissues via energy-based modalities, including electrosurgery, radiosurgery, gamma knife, brachytherapy, cryogenic therapy, fluidjet therapy (hydrotherapy), microwave ablation, radiofrequency ablation, laser, thermal ablation, and ultrasonic ablation. The report describes the energy-based technologies in terms of the nature of their effect on soft tissue, the underlying basis of the technology, the requisite systems for their use (including capital equipment, devices and disposables), and their strengths and weaknesses for specific clinical applications. The report details current and anticipated target applications and assesses the current and forecast caseload for each energy-based therapeutic considering competition from any and all alternative energy-based or other therapeutics for the following clinical areas: General surgery, Cardiac, Gynecologic, Orthopedic. The report presents current and worldwide market forecasts (2008-2017) segmented by technology type and specific clinical segment. The report also provides regional segmentation of the caseload; e,g., USA, Japan, Europe, RoW. The report will details the current and emerging products, technologies and markets for each energy-based therapy. The report profiles over 60 key companies in this industry detailing their current products, current market position and products under development. The report is detailed, with table of contents and list of exhibits at Worldwide Ablation Technologies.
About MedMarket Diligence
MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries. The company publishes a dedicated market and technology reports on a range of clinical and technolgy subjects and offers the Medtech Startups Database.